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Abstract
The chemically-synthesized siRNA duplex has become a powerful and widely used tool for RNAi loss-of-function studies, but
suffers from a high off-target effect problem. Recently, endoribonulease-prepared siRNA (esiRNA) has been shown to be an
attractive alternative due to its lower off-target effect and cost effectiveness. However, the current manufacturing method
for esiRNA is complicated, mainly in regards to purification and normalization on a large-scale level. In this study, we present
a magnetic bead-integrated chip that can immobilize amplification or transcription products on beads and accomplish
transcription, digestion, normalization and purification in a robust and convenient manner. This chip is equipped to
manufacture ready-to-use esiRNAs on a large-scale level. Silencing specificity and efficiency of these esiRNAs were validated
at the transcriptional, translational and functional levels. Manufacture of several normalized esiRNAs in a single well,
including those silencing PARP1 and BRCA1, was successfully achieved, and the esiRNAs were subsequently utilized to
effectively investigate their synergistic effect on cell viability. A small esiRNA library targeting 68 tyrosine kinase genes was
constructed for a loss-of-function study, and four genes were identified in regulating the migration capability of Hela cells.
We believe that this approach provides a more robust and cost-effective choice for manufacturing esiRNAs than current
approaches, and therefore these heterogeneous RNA strands may have utility in most intensive and extensive applications.
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Introduction
RNA interference (RNAi) is an intrinsic cellular mechanism for
mediating gene expression, and has been established as a
commonly used tool for gene down-regulation and loss-of-function
studies in the life sciences [1]. The siRNA duplex and shRNA are
generally chemically synthesized and used for experimental
analysis in mammalian cells [2]. Endoribonuclease-prepared
siRNA (esiRNA), which is generated by bacterial RNase III
digestion of a long dsRNA, is a mixture of siRNA-like molecules of
heterogeneous strands that all target the same transcript; these
esiRNA thus can produce the same silencing efficiency with a 12-
fold lower off-target effect compared to chemically synthesized
siRNA [3–6]. Accordingly, esiRNA has recently attracted the
attention of researchers due to both its reduced off-target effect
and cost-effectiveness.
For example, Kittler et al. identified over 1,000 new genes
required for cell division based on results from their high-
throughput cell viability screening [5]. Collinet et al. systematically
investigated and identified several novel components in the
transferrin (TF) and epidermal growth factor (EGF)-related
endocytic trafficking [7]. In addition, Fazzio et al. demonstrated
that esiRNAs are highly effective in RNAi-mediated gene silencing
in embryonic stem cell (ESCs), while Tan et al. showed that
esiRNAs were able to inhibit HBV replication more efficiently
than synthesized siRNAs and tolerated limited target sequence
variations without losing inhibitory capacity [8,9].
The production of esiRNA, however, is a complex process
involving multiple steps, including product purification, quantifi-
cation and normalization. As RNase III enzymes do not
completely digest long dsRNAs, the purification step is essential.
In addition, normalization of esiRNA prior to transfection is a
critical but tedious task. We previously demonstrated the
manufacture of hundreds of esiRNAs using a polymer mi-
crobead-integrated chip [10]. Here, we report further simplifica-
tion of the manufacturing process and describe a magnetic bead-
integrated chip that is capable of manufacturing hundreds of
ready-to-use esiRNAs simultaneously. Furthermore, we present
two functional assays using the esiRNAs, which demonstrates their
successful production and application in cell function analysis, and
illustrates the robustness of this chip.
Results and Discussion
The chip contained two components: a microwell array and
magnetic microbeads coated with streptavidin (Figure 1A). The
utilization of this chip allows the process of large-scale production
of esiRNA to be simplified into three main steps: target
amplification and immobilization, transcription, and enzymatic
digestion (Figure 1B).
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39419Figure 1. Manufacture of esiRNA by means of a magnetic bead-integrated chip. A. The schematic diagram shows the chip composed of a
microwell array and magnetic beads coated with streptavidin. B. Large-scale manufacture of esiRNAs can be divided into three steps: target
amplification and immobilization, transcription, and enzymatic digestion. C. Confirmation of PCR reactions using biotinylated or non-biotinylated
primers. Amplification products (left), transcription products (middle), or esiRNA products (right) are detected only when biotinylated DNA primers
are used. B: biotinylated primers.
doi:10.1371/journal.pone.0039419.g001
Figure 2. The normalization of esiRNA products. A. A range of initial amounts of DNA template were assayed (100, 10, 1, and 0.1 ng, each in
5 mL in volume). After the immobilization and transcription steps, the variation of transcription products was within 20%. The final esiRNA products
had a variation of less than 10% when the initial amount of DNA templates was in the range of 0.1–100 ng. B. Eight esiRNA products were
manufactured in parallel. The standard deviation among these eight products was approximately 3%.
doi:10.1371/journal.pone.0039419.g002
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cloned cDNA fragments or chip-based, chemically-synthesized
DNA oligomers, were dispensed into a microwell chip as the PCR
template. One of the two PCR primers was biotinylated to facilitate
theimmobilizationoftheamplificationproductsonbeadsafterPCR
andthesubsequenteasyseparationfromthesupernatantcontaining
dNTPs, DNA polymerase and buffer solution. To ensure that the
templates were successfully immobilized, these beads were em-
ployed as templates for another PCR reaction. Amplification
products were detectable in the supernatant when templates were
generated from biotinylated primers, whereas no products were
detected in the control reaction containing templates using non-
biotinylated DNA primers (Figure 1C).
Next, the product-immobilized microbeads were incubated with
in vitro transcription buffer as well as T7 RNA polymerase, and
large amounts of complimentary RNA strands were generated.
Then, the DNA-immobilized microbeads were then removed, and
a specific amount of magnetic microbeads tagged with a
hybridization probe was added so that the beads would act as
bait for the duplex via hybridization (Figure S1). After stringent
rinsing, these RNA duplexes on the beads were enzymatically
digested into esiRNAs, followed by the removal of magnetic beads.
As expected, only biotinylated DNA products generated in vitro
transcripts and subsequent esiRNA products (Figure 1C).
Removal of PCR and transcription supernatant from esiRNA
products is critical, as the under- or over-digested RNA fragment
contaminants would cause adverse effects on cells. Traditional
purification procedures often involve centrifugation or even
electrophoresis, which are both time-consuming and labor
intensive in regards to large-scale level synthesis of esiRNAs.
The magnetic bead-integrated chip reported here allowed quick
and simple purification using a centrifuge-free approach; notably,
Figure 3. The silencing specificity and efficiency of esiRNAs. A. Fifteen GFP esiRNAs generated in parallel potently inhibited the fluorescent
signal in cells cotransfected with GFP-encoding vectors; in contrast, five PLAU esiRNAs had no effect on the fluorescent intensity compared to control
experiments. B. & C. Quantitative analysis of the silencing efficiency of esiRNA products. The qRT-PCR results showed that esiRNAs manufactured on
the magnetic beads can efficiently inhibit expression levels of the respective genes. A western blot assay showed that esiRNAs targeting TP53, TGFB1,
PLAU, or TGFBR2 inhibited therespective protein expression levels by up to approximately 50%.
doi:10.1371/journal.pone.0039419.g003
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for electrophoresis or precipitation steps.
Our method allows for quantification and normalization of
esiRNA products by tailoring the amount of magnetic beads in
eithertheimmobilizationorhybridizationstep.Sincetheamountof
transcription and digestion products mainly depended on the
number of probes, we optimized the concentration of magnetic
beads (Figure S2). Given the cost and yield, we chose the final
concentrations of 8 fM or 0.4 pM of magnetic beads for immobi-
lization and hybridization steps, respectively. Our results showed
that a three-order magnitude difference of initial DNA template
input(0.1–100 ng)couldresultinavariationofnomorethan20%of
thetranscriptionproductsifthesameamountofmagneticbeadswas
added during the immobilization step (Figure 2A). The variation in
the production of esiRNA became smaller (approximately 10%) if
the amount of magnetic beads was further controlled during the
hybridizationstep.Inordertofurtherconfirmthereproducibilityof
these results, eight esiRNA products were manufactured in parallel.
Less than 3% variation was observed in either the transcription or
digestion products (Figure 2B). These results indicate that the
amount of esiRNA products can be normalized by controlling the
amount of microbeads.
To evaluate the silencing specificity and efficiency of the
esiRNAs generated by our novel approach, we manufactured
twenty esiRNAs in parallel, including fifteen for GFP and five for
PLAU, and co-transfected each of them along with an eGFP
vector into 293 T cells. The results demonstrated that only the
eGFP esiRNA could silence eGFP protein expression levels, while
PLAU esiRNA had no effect (Figure 3A). Next we produced seven
esiRNAs, each targeting an endogenous gene, and quantitatively
assessed the silencing efficiency. Quantitative RT-PCR results
showed that endogenous expression levels of all genes were
inhibited by up to 50% (Figure 3B). We then examined the
expression level of the proteins encoded by four of the genes
(TP53, TGFB1, TGFBR2 and PLAU) using western blot analysis
48 hours after transfection. We observed that esiRNAs manufac-
tured by either our method or the traditional approach resulted in
a significant silence efficiency of approximately 50% (Figure 3C).
Many cellular pathways and mechanisms are potentiated by
multiple factors that work in concert to synergistically regulate
downstream events. For example, cells deficient in BRCA1 were
shown to be highly sensitive to additional PARP1 inhibition or
knock-down, resulting in cell death via apoptosis [11,12].
Therefore, we next investigated the ability of our approach to
assess the effects of inhibiting two or more genes on certain cellular
responses simultaneously. We were able to successfully manufac-
ture three pairs of esiRNAs (PARP1 and BRCA1, PARP1 and
GFP, and BRCA1 and GFP), each pair in a single well in which
both DNA templates were simultaneously amplified and immo-
bilized on magnetic beads. Our results confirmed that the presence
of two templates together in a single well did not influence the
production and normalization of the two esiRNAs (Figure 4A).
Furthermore, quantitative RT-PCR confirmed that a mixture of
PARP1 and BRCA1 esiRNAs resulted in efficient silencing of both
genes (Figure 4B). Importantly, both the MTS assay and cell
survival assay showed that inhibition of either PARP1 or BRCA1
did not induce significant cell death, while silencing of both genes
severely impacted cell viability (Figure 4C and 4D). Thus, our chip
could readily manufacture a pair of normalized esiRNAs, such as
PARP1 and BRCA1, which could subsequently and immediately
be used in functional analysis of their synergistic effects.
Cellmigrationisanessentialfeatureofthemetastasisprocess,and
the identification and characterization of molecules that control cell
migrationcouldprovideabetterunderstandingofcancermetastasis.
We used our novel magnetic bead-integrated chip approach to
generateasmallesiRNAlibrarytargeting68genesfromthetyrosine
kinase family. A self-assembled cell microarray, which we recently
developed, allowed the high-throughput screen of functional genes
Figure 4. Synergistic effects of esiRNAs. A. The simultaneous production of two normalized esiRNAs in one well. B. The qRT-PCR results showed
that the mixture of PARP1 and BRCA1 esiRNAs could effectively silence the expression of both genes. C. & D. The MTS assay and cell survival assays
showed the synergistic effect of PARP1 and BRCA1 genes.
doi:10.1371/journal.pone.0039419.g004
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FLT1 and IGF1R were found to significantly up- or down-regulate
themigrationofHelacells(Figure5AandTableS1).Toconfirmthis
finding,weselectedninegenes(includingEPHB2,RYK,FLT1,and
IGF1R) from the library and synthesized the siRNAs. Consistently,
only the siRNAs against the fourgenes were found to have the same
effect as the corresponding esiRNAs in influencing the migration of
Hela cells (Figure 5B). These results show that the magnetic bead-
integrated chip could be easily adapted to a genome-scale screen.
Insummary,ourstudyhasdemonstratedaconvenientandrobust
approach for the large-scale manufacture of ready-to-use esiRNAs.
This magnetic bead-integrated chip not only simplified the
complicated steps in esiRNA preparation, such as amplification,
transcription and enzymatic digestion, but also showed other
advantages over traditional methods. First, the traditional methods
involve the purification, quantification and normalization of liquid
samples and require expensive instruments as well as demanding
skills,whichprofoundlyhamperthemanufactureandapplicationof
esiRNAsonalarge-scalelevel.Second,itwouldbeaseverelytaxing
task to quantify them one by one, as would be the case in the
traditionalmethods.Withtheuseofmagneticbeads,wecouldeasily
separate the amplification and transcription products from buffer
solutionsandcomponents.Furthermore,wecouldtailortheamount
of esiRNA product by controlling the number of magnetic beads in
the immobilization or hybridization steps. Our functional studies
further showed that these esiRNAs could be immediately applied to
loss-of-function studies without the need for any additional
treatment. Interestingly, this approach can readily manufacture
two or more normalized esiRNAs in a single well, which can be
subsequently used to study the synergistic effects of the genes on cell
viability. Thus, this new approach provides a more robust and cost-
effective choice for manufacturing esiRNAs.
Materials and Methods
Preparation and Immobilization of DNA Template on
Streptavidin-magnetic Beads
For each target gene, we design and obtain a double-strand
DNA template of 400–500 bp in length tagged with a pair of
adapters, which were used for hybridization and in vitro
transcription. A T7 promoter sequence for in vitro transcription
was added at each end. Thus, the entire gene sequence was: 59-
GCTCCGGA AAGCAACCCGACTAATACGACTCACTA-
TAGG (certain target DNA) CCTATAGTGAGTCGTATTAC-
GAGGCCTTTCG TTGGGCTG -39. Biotinylated PCR primer
and reverse primer were as follows: Forward 59-biotin-
Figure 5. Screen and validation of tyrosine kinase genes capable of regulating the cell migration. A. Self-assembled cell microarray
screen of genes capable of regulating the migration of Hela cells by use of esiRNA tyrosine kinase library. B. Validation of the esiRNA screen results by
use of siRNAs and transwell assay.
doi:10.1371/journal.pone.0039419.g005
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CAACGAAAGGCCTCG-39.
Streptavidin (SA)-coated magnetic beads were purchased from
Invitrogen (Dynal MyOne C1). Biotinylated DNA templates were
immobilized on these beads following the standard protocol
provided by the manufacturer.
Fabrication of the Microchip
The microwell chip was composed of two parts, a 96-well or
384-well plate, and a magnetic mask. The latter was assembled
from a group of magnetic bars so that the bar came in close
contact with the well when removing the magnetic beads.
In vitro Transcription and esiRNA Production on Beads
In vitro transcription (IVT) was carried out in reaction buffer
containing T7 RNA polymerase (NEB). The magnetic beads
containing immobilized DNA template were incubated with IVT
buffer at 37uC for 4 h with shaking.
Once transcription finished, the DNA template immobilized
magnetic beads were removed, and tag-probe immobilized
magnetic beads (Invitrogen, Dynal MyOne T1) resuspended in1
X SSC were added into the supernatant. The mixture was then
heated to 95uC, slowly cooled down to 65uC, and incubated at
65uC for 1 h. After these performances, dsRNA duplex would
anneal and hybridize onto beads via tag-probes. Washing with
0.56SSC, at least 3 times, would remove the excessive transcrip-
tion solution and DNA templates.
The magnetic microbeads were easily removed after the
transcription or the digestion step using a 96-magnetic needle
plate, which was assembled with a group of electromagnetic steel
needles.
Finally, following the siRNaseIII (Takara) protocol, enzymatic
digestion was performed at 30uC with shaking. After 1 h,
enzymatic digestion was terminated by adding EDTA. The
supernantant esiRNA products were stored at 280uC until the
subsequently used for transfection. The digested products were
transferred into another plate for transfection with the aid of the
magnetic mask.
esiRNA Transfection, Real-time PCR, Western Blot and
Cell Viability Assay
esiRNAs were transfected into 293 T or Hela cells using
Lipofectamine 2000 (Invitrogen) according to the manufacture’s
instruction. Cells were collected at 48 h for the real-time PCR and
western blot assay, or at 72 h for the cell survival and MTS assays.
Cell lysis and protein extractions of 293 T or Hela cells were
performed following the indicated procedures. Antibodies against
TP53, PLAU, TGFBI, TGFBR2 and GAPDH were purchased
from CST or Abcam, respectively. Sequences of qRT-PCR
primers are listed in Table S2.
Real-time PCR and western blot assays were carried out
following a standard protocol.The MTS Cell viability assay was
performed following the instruction of CellTiter 96H AQueous
Non-Radioactive Cell Proliferation Assay Kit (Promega, USA).
Transwell Assay and Self-assembled Cell Microarray for
the Cell Migration Study
For transwell migration assays, Hela cells were seeded into the
upper chamber of a Transwell insert (pore size, 8 mm; Costar) in
100 ml serum-free medium per well. Medium (600 ml) containing
10% serum was added in the lower chamber to function as a
chemoattractant. Non-migratory cells were removed from the
upper chamber by scraping the surface with a cotton bud. The
cells remaining on the lower surface of the insert were fixed with
2% formaldehyde (Sigma, USA) and stained by DAPI (Roche,
USA). Self-assembled cell microarray screening assay was
performed according to our previously described study [13].
Supporting Information
Figure S1 Schematic diagram of the process for man-
ufacturing esiRNA using magnetic beads integrated on a
chip. GSP represents gene specific primers.
(TIF)
Figure S2 Optimization of the concentrations of mag-
netic beads. A. Different amounts of magnetic beads were used
during the immobilization step. The transcription products were
normalized. B. Different amounts of Tag-probe immobilized
beads were added before the hybridization step. The yield of
esiRNA products was normalized.
(TIF)
Table S1 Migration assay using the esiRNA tyrosine
kinase library. The esiRNAs were manufactured using the
magnetic bead-integrated chip approach. Samples 1, 2 and 3
represent three different esiRNAs all targeting one gene,
respectively.
(DOC)
Table S2 Sequences of qRT-PCR primers used in the
experiments.
(DOC)
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